Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2024-04-05 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges and depositories providing details about shares dematerialized during March 2024. It references Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, and includes a certificate from the company's Registrar and Transfer Agent (RTA) confirming the dematerialized shares as of March 31, 2024. The document is informational and regulatory in nature, reporting compliance with share dematerialization disclosure requirements. It does not contain financial statements, management discussion, or detailed financial results. It is not a report itself but a regulatory filing informing the exchanges and depositories about share dematerialization status. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (3316 characters), and it is a formal notification rather than a report or announcement of a report publication.
2024-04-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2024. It is issued by the Registrar and Transfer Agent confirming compliance and is addressed to stock exchanges. The document is short (1447 characters) and does not contain financial statements or substantive financial data. It is a certification letter rather than a full report or announcement of financial results. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and does not qualify as an Interim Report or any other detailed financial report.
2024-04-05 English
Cessation
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the completion of tenure of Independent Directors of the company. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations and provides details about the cessation of directors due to completion of their term. There is no financial data, no report attached or referenced as being published, and the content focuses solely on changes in the board of directors. This fits the category of Board/Management Information (MANG). The document length is 3421 characters, which is relatively short but contains substantive information about management changes, not just an announcement of a report publication or a regulatory filing. Therefore, the appropriate classification is MANG with high confidence.
2024-04-01 English
Cessation
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the completion of tenure of Independent Directors of the company. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations and provides details about the cessation of directors due to completion of their term. There is no financial data, no report attached or referenced as being published, and the content focuses solely on changes in the board of directors. This fits the category of Board/Management Information (MANG). The document length is 3421 characters, which is relatively short but contains substantive information about management changes, not just an announcement of a report publication or regulatory filing.
2024-04-01 English
Cessation
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the completion of tenure of Independent Directors of the company. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations and provides details about the cessation of directors due to completion of their term. There is no financial data, earnings information, or report attached. The content is about changes in the company's board of directors, specifically the cessation of Independent Directors after their term ended. This fits the category of Board/Management Information (MANG). The document length is 3421 characters, which is relatively short but contains substantive information about management changes, not just an announcement of a report publication or a regulatory filing. Therefore, the appropriate classification is MANG with high confidence.
2024-04-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the announcement of audited financial results for the quarter and financial year ending March 31, 2024. It references the upcoming audited financial results but does not contain any financial data or the results themselves. The document is short (1719 characters) and serves as an announcement related to compliance with insider trading regulations. It is not the financial report itself, nor a transcript or presentation. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-03-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.